What is LENZ Therapeutics, Inc.'s stock symbol?

Our stock is traded on the Nasdaq under the symbol LENZ.

When was LENZ Therapeutics, Inc. incorporated?

LENZ Therapeutics, Inc. (LENZ Therapeutics or the Company), previously known as Presbyopia Therapies, Inc., became a corporation in Delaware on October 28, 2020, upon the filing of a Certificate of Conversion to convert Presbyopia Therapies, LLC, a Delaware limited liability company (formed in September 2013) to a Delaware corporation.

Where is LENZ Therapeutics, Inc. located?

445 Marine View Ave.
Suite 320
Del Mar, CA 92014

When is LENZ Therapeutics, Inc.'s fiscal year end?

December 31st

Who is LENZ Therapeutics, Inc.'s transfer agent?

Equiniti Trust Company, LLC
48 Wall Street
New York, NY 10005
T: 800-937-5449

Who is LENZ Therapeutics, Inc.'s independent auditor?

Ernst & Young LLP
4365 Executive Drive
San Diego, CA 92121

Who is LENZ Therapeutics, Inc.'s outside legal counsel?

Wilson Sonsini Goodrich & Rosati, P.C.
Dan Koeppen
12235 El Camino Real
San Diego, CA 92130
T: 858-350-2300

Other Tax Information

Issuers of corporate securities are required to complete Internal Revenue Service Form 8937 to report organizational actions, including nontaxable distributions that affect the basis of the securities involved in the organizational action. The tax information contained herein is provided for informational purposes only and should not be construed as legal or tax advice. LENZ does not provide legal or tax advice. Stockholders should consult their own legal, financial or tax advisors to determine the income tax consequences of their specific situation.

Form 8937